“Higher” Oncotype score & hormonal therapy only?
Hello,
I hope it is ok to ask this question here, I am 50 years old and I found out my Onco score is 27. I had a mastectomy (left breast) and no node involvement. My MO wasn't happy with my score and thought my score would have been lower because My receptor status was so strong. I am trying to weigh out if the risk of the side effects of chemo are worth it. My 10 year risk of recurrence with hormone treatment alone is 18% and with adding chemo it would be around 11%.
Thanks for any help
Comments
-
What is your cancer grade and mitotic score? I had an oncodx score of 34 and I didn't do chemo against recommendations. I had 2 tumors each 1cm no nodes, grade 1 & 2 er 95% pr 0%. My mitotic scores were 1 on both tumors. I did 4 years on AI drugs.
I also had left mastectomy.
-
and what is your recurrence score with rads and hormone tx? I scored 36 oncotype with a grade 3 stage 1 tumour. I weighed everything very carefully and decided on all 3 tx. But would gleefully have bypassed chemo if at all possible.
-
It’s a tough call but one only you should make because after all it’s your body and your life. That’s not to say you shouldn’t strongly consider the advice of your medical team because they are the experts.
Then there are the side effects that will probably come with having chemo.
There are ladies who have had minimal side effects and others who suffered debilitating ones with chemo. There’s no way to know beforehand how it will be for you. What about your QOL?
I didn’t have chemo because my score was 11. I had IDC, Stage 1b, Grade 1. I had a lumpectomy and radiation - 33 treatments in all. I had a little burning
and fatigue halfway through my treatments but that’s it. I’m not sure what I would have done if I had been faced with the decision to have chemo or not.
You of course can roll the dice. Just be sure you don’t second guess yourself or look back and wonder what if..
Good luck whatever you decide.
Diane -
I think if mine had been grade 3 and larger size I would have thought more about it especially with the oncodx of 34. Also need to understand the risks associated with treatment.
-
CPB, what was your tumor size, cancer grade, and Ki-67 score? This would tell us/you how fast growing it was and might explain your Oncotype score.
-
I am not familiar with the terminology (what is the ki-67 score?), here is the path report, I realize this is my decision but more explanation of what this report means would be great. Thanks.
- Tumor #1 is grade 2 (3+2+2) and 2.1 cm in maximum dimension.
- Tumor #2 is grade 1 (2+2+1) and 1.6 cm in maximum dimension.- Ductal carcinoma in situ (DCIS), nuclear grade 2, cribriform type, with necrosis andmicrocalcifications.
BREAST INVASIVE CARCINOMA CASE SUMMARY
Lymph node sampling: Sentinel lymph node(s)
Microscopic
Tumor size: 2.1cm
Histologic type: Invasive carcinoma of no special type (ductal, not otherwise specified)
Histologic grade (Nottingham): Grade 2 (scores of 6 or 7)
Tubule formation: Score 3
Nuclear pleomorphism: Score 2
Mitotic rate: Score 2
Prognostic markers: Performed on accession/block #: GHS-18-4374 part A
Estrogen receptor: Positive
Percent cells staining: 91-100%
Staining intensity: Strong
Progesterone receptor: Positive
Percent cells staining: 81-90%
Staining intensity: Strong
HER2 immunohistochemistry: Negative (1+)
Radiographic correlation: Preoperative imaging report(s) were reviewed.
Tumor focality: Multiple biologically separate invasive carcinomas
Features of separate invasive carcinoma(s)
See Additional Findings section below
Ductal carcinoma in situ: Present
Negative for extensive intraductal component
Comment(s): Predominantly associated with tumor #2 (butterfly clip)
Treatment effect: No known presurgical therapy
Lymph-vascular invasion: Present
Microcalcifications: Present in DCIS
Margins: Uninvolved by invasive carcinoma:
Distance from closest margin: >1 cm
Closest: Posterior margin and: Uninvolved by DCISDistance from closest margin: >1 cm
Closest: Posterior margin
Regional lymph nodes
Number with macrometastasis: 0
Number with micrometastases: 0
Number with isolated tumor cells only: 0Total number of lymph nodes examined: 4
Number of sentinel nodes examined: 4
Pathologic staging (pTNM)
TNM descriptors: m (multiple primary tumors)
Primary tumor (pT): pT2
Regional lymph nodes (pN): pN0
pN modifier: (sn)Additional findings
Features of separate invasive carcinoma(s):
Tumor #2: Invasive ductal carcinoma, grade 1, 1.6 cm (measured microscopically from slide E16; 1.4 cm on US).
ER positive (>91%; strong intensity), PR positive (>91%; strong intensity) and HER2 negative (score 1+)
Optimal block for special studies: Tumor #1 (E11) and tumor #2 (E16) -
based on the most recent TAILORx study, you are a candidate for chemo.
https://www.cancer.gov/news-events/press-releases/2018/tailorx-breast-cancer-chemotherapy
Until recently, patients like yourself with “intermediate” OncotypeDX scores, clinicians were not sure if the benefits of chemo outweighed the risks. A few months ago, the long awaited TAILORx study results were released. Now, clinicians feel more comfortable recommending chemo for patients with your score.
That said, it is your decision. You might ask for a second opinion if you are still unsure. Good luck
-
With a score of 27 AND lymph vascular invasion AND a 7 point difference in recurrence rates I would have been comfortable taking the chemo. That said, it is always what YOU are comfortable with. Wishing you all the best in whatever decision you make!!!!
-
CPB: the Ki-67 is a marker for cell proliferation. Instead, your pathologist counted mitotic cells and obtained a mitotic rate. Yours was in the intermediate range. Your report suggests that you would be a good candidate for chemo. But if conflicted, do get a second opinion.
I had to hear three doctor recommendations before I was ready to move forward!
-
Does the Oncotype DX accurately predict the increased benefit of having chemo when one has a higher score? I read an article in Annals of Oncology, "Prediction of benefit from chemotherapy in ER-positive/Her2-negative breast cancer--a problem still to be solved" that would suggest that the inclusion of some Her2+ women in the NSABP-B20 and SWOG-8814 trials could affect the stated level of cheotherapy benefit. The authors state "We conclude that neither the RS nor any other currently used gene expression test has demonstrated its ability to predict a benefit from chemotherapy treatment in patients with ER-positive/HER2-negative tumors. Nevertheless, validated gene expression tests providing information incremental to established risk factors continue to be a valuable tool to identify patients with low risk of recurrence having low absolute benefit from chemotherapy."
My initial diagnosis on June 19 by needle biopsy as follow up for my suspicious mammo was IDC, Stage 1, grade 1. I had a partial mastectomy on July 12. My tumor was classified as pT1c N(sn)0. Although the margins were negative, focal DCIS grade II (Intermediate) was also found with no "xtensive intraductal component. Interesting that intermediate grade for DCIS is defined as "neither well-differentiated nor poorly differentiated," I had a close margin of <1 mm for the DCIS, and I elected to have a re-excision on August 16 to get a larger margin. Both surgeries were a piece of cake for me. i finally got the OncotypeDX score back on August 28. Result was 31, which puts me at the bottom of the high risk group.
I am 70, in very good health and and do not take prescription meds except an infrequent Ambien. I exercise very regularly (cardio and weight-bearing), limit alcohol to
-4 drinks/week, have a good diet, and a good weight with BMI of 24. There is no history of breast cancer in maternal family (unknown paternal hx). I nursed 5 babies for a total time of almost 12 years, and had prior mammograms which said that I had a 4.5% lifetime risk of BC. Go figure.
Both MOs I have consulted with are recommending 4 cycles of T-C (Taxotere and cyclophosphamide.) One MO likes Tamoxifen and the other, an Aromatase Inhibitor with Zometa for my low bone density along with the chemo. I have deferred starting any treatment until after i return from a long awaited and already once-postponed trip to South America.
I am hoping that someone with a similar profile/experience will offer me their thoughts/outcomes/concerns about chemo and anti-estrogen therapy. I have not made up my mind which path I will take. Thank you for reading.
-
lactcon..., what is your pr percentage? I am including a link for you.
https://www.breastcancer.org/symptoms/diagnosis/in...
-
lact...the study you refer to is from 2014. Subsequently, the long awaited TAILORx study was presented this year. The results should be part of your discussion with your team. TAILORx was important because it tried to measure whether those patients with “intermediate Oncotype DX scores would benefit from chemo.
Here are the results:
With the TAILORx study, we can now say that for certain cohorts of patients, the benefits of chemo outweigh the risks. Based on your score, you would see some benefit.
That said, you mention that you are relatively healthy. So are many of us. I was 53 when diagnosed. I exercised, ate well, have a BMI of 24, and like you, STILL got breast cancer. I wish I could say that lifestyle will keep a recurrence at bay. But, sadly, it didn't prevent you or me from getting it and I sincerely doubt it will keep us from recurring.
At 70, you are still young...and healthy. I hope you will read the TAILORx study and have a fruitful discussion with your team....good luck
-
I think I read somewhere my ER status was 100% positive. PR status is negative.
-
You may want to do AI drugs if you are post menopausal, anastrozole works well for er+ and pr-.
-
Thank you Meow13. I am leaning toward doing just the endocrine therapy, even though both Tam and the AIs have SE's that are not to be underestimated. Perhaps I need a 3rd opinion to be the tie-breaker...
Voraciousreader. I had heard about the TailorX study and appreciated the link you provided. Thank you. A quote from the NCI press release about it:
"The findings suggest that chemotherapy may be considered for the remaining 30 percent of women with HR-positive, HER2-negative, node-negative breast cancer as in 'any age with a recurrence score of 26–100 (17 percent)"
Interesting that it says "may." I wish the ages of the trial participants who made up this % were part of the report.
Another point to consider for me. Wouldn't younger women have more of a chance of returning to a similar functional status that they had before chemo than older women? This is what worries me most about chemo. Yes I might live longer with chemo, but at what cost to being able to fully appreciate life in the here and now, and continue to do all things I do now for as long as I can?
Still considering options, but luckily I have another month and a half before I have to come to a decision. Thank you for reading.
-
Thank you Meow13. I am leaning toward doing just the endocrine therapy, even though both Tam and the AIs have SE's that are not to be underestimated. Perhaps I need a 3rd opinion to be the tie-breaker...
Voraciousreader. I had heard about the TailorX study and appreciated the link you provided. Thank you. A quote from the NCI press release about it:
"The findings suggest that chemotherapy may be considered for the remaining 30 percent of women with HR-positive, HER2-negative, node-negative breast cancer as in 'any age with a recurrence score of 26–100 (17 percent)"
Interesting that it says "may." I wish the ages of the trial participants who made up this % were part of the report.
Another point to consider for me. Wouldn't younger women have more of a chance of returning to a similar functional status that they had before chemo than older women? This is what worries me most about chemo. Yes I might live longer with chemo, but at what cost to being able to fully appreciate life in the here and now, and continue to do all things I do now for as long as I can?
Still considering options, but luckily I have another month and a half before I have to come to a decision. Thank you for reading.
-
lact....regarding age....TailorX also mentions age...for those patients younger than 50, with scores beginning at 16, they should consider chemo. So....patients of any age with scores beginning at 25 should benefit AND patients less than age 50, with scores beginning at 16 should benefit.
Another study that might be interesting to premenopausal women would be the SOFT and TEXT trials....
http://www.ascopost.com/issues/july-25-2018/8-year-update-of-soft-and-text-trials/
-
Lactcondoula: I'm guessing the Grade 1 IDC was Oncotyped and found to be a 31?! Both MOs are probably recommending TCX4 because of your Oncotype score and your overall good health.
Here is an interesting article about treatment options and explanations for 70 yo ladies with your type of BC.
-
Lactcondoula, the score is probably that high from pr 0% coupled with highly er positive.
Here is an article there is another one dated 2014 basically saying same thing, Tamoxifen doesn't work as well.
http://www.cancernetwork.com/articles/anastrozole-...
Something to consider when you are low grade, the combination er+ pr- has been associated with more aggressive behavior. AI drugs seem to be very effective in our case.
Lmurphy, I suspect your tumor falls into the more aggressive category.
-
Ahh, I missed the PR-. That would explain the RS 31.
-
I don't include my stat summary because of the public nature of BCO and the tracking with outbrain. It is kind of a pain to write each time in my post but I feel more comfortable doing that.
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team